Glymphatic system: a pathway for managing endogenous metabolites in CNS

Glymphatic system: a pathway for managing endogenous metabolites in CNS

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2017.

Dettagli Bibliografici
Autore principale:	Tasneem, Sadia
Altri autori:	Archie, Sabrina Rahman
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2021
Soggetti:	Glymphatic pathway Alzheimer’s disease CNS Molecular diagnosis Alzheimer's disease > Diagnosis
Accesso online:	http://hdl.handle.net/10361/14373

Documenti analoghi

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
di: Chowdhury, Sariya Uzrat
Pubblicazione: (2022)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
di: Aziz, Farhin
Pubblicazione: (2019)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
di: Saha, Bithi Rani
Pubblicazione: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
di: Alim, Abdul
Pubblicazione: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
di: Afra, Sumaiya
Pubblicazione: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
di: Tabassum, Nadira
Pubblicazione: (2024)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
di: Karmaker, Swastika
Pubblicazione: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
di: Shehab, Habibul Mohsin
Pubblicazione: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
di: Islam, Md. Irfath
Pubblicazione: (2023)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
di: Mahee, Sadique Abdal
Pubblicazione: (2024)

Role of circular RNA in neurological disease
di: Salsabil, Labiba
Pubblicazione: (2024)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
di: Tamanna, Mst. Taskia
Pubblicazione: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
di: Hassan, Md. Muhtaz
Pubblicazione: (2020)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
di: Bakar, Osama Bin Abu
Pubblicazione: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
di: Jahan, Nusrat
Pubblicazione: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
di: Tasin, Md Abtahi
Pubblicazione: (2023)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
di: Mostofa, Golam
Pubblicazione: (2022)

Alzheimer's disease and marriage : an intimate account /
di: Wright, Lore K.
Pubblicazione: (1993)

Potential treatments for epigenetic dysregulation in neurological diseases
di: Zaman, Rubaiyat
Pubblicazione: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
di: Dey, Manashi
Pubblicazione: (2024)

A literature review on the efficacy of test kits for COVID-19
di: Sajid, Saiara Sajita
Pubblicazione: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
di: Aana, Afsara Sumon
Pubblicazione: (2021)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
di: Halim, Rabea
Pubblicazione: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
di: Ferdous, Labiba
Pubblicazione: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
di: Rahman, Quazi Ashikur, et al.
Pubblicazione: (2022)

Marine compounds in the treatment of Alzheimer’s disease
di: Parveen, Sanjana
Pubblicazione: (2022)

Skeleton /
di: Parkin, Peter

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
di: Haque, Mushfiqul
Pubblicazione: (2019)

An ambient assisted living system for Alzheimer’s patients
di: Abedin, Minhajul, et al.
Pubblicazione: (2023)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
di: Rithin, Rafia Islam
Pubblicazione: (2022)

A review on adult neurogenesis in Alzheimer’s disease
di: Akter, Moriam
Pubblicazione: (2022)

Gene editing for neurodegenerative diseases-A review
di: Sharna, Anika Islam
Pubblicazione: (2023)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
di: Roy, Aditya, et al.
Pubblicazione: (2023)

Early detection of lung cancer risk using data mining
di: Ahmed, Kawsar, et al.
Pubblicazione: (2016)

Deep learning based early Glaucoma detection
di: Islam, Aabrar, et al.
Pubblicazione: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
di: Sani, Mehedi Hasan, et al.
Pubblicazione: (2022)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
di: Mahbub, Riasat, et al.
Pubblicazione: (2022)

The role of Artificial Intelligence (AI) in the detection and diagnosis of chronic diseases – a review
di: Zaman, Mumtahina
Pubblicazione: (2022)

In vivo evaluation of CNS depressant and antinociceptive activities of different extracts of trewia polycarpa leaves
di: Akter, Nahid
Pubblicazione: (2015)